- Home
- STRM vs TENX Comparison
STRM vs TENX Comparison
Compare STRM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- TENX
- Stock Information
- Founded
- STRM 1989
- TENX 1967
- Country
- STRM United States
- TENX United States
- Employees
- STRM N/A
- TENX N/A
- Industry
- STRM EDP Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- TENX Health Care
- Exchange
- STRM Nasdaq
- TENX Nasdaq
- Market Cap
- STRM 22.3M
- TENX 21.6M
- IPO Year
- STRM 1996
- TENX N/A
- Fundamental
- Price
- STRM $5.19
- TENX $5.77
- Analyst Decision
- STRM
- TENX Strong Buy
- Analyst Count
- STRM 0
- TENX 3
- Target Price
- STRM N/A
- TENX $16.00
- AVG Volume (30 Days)
- STRM 38.1K
- TENX 44.6K
- Earning Date
- STRM 06-16-2025
- TENX 08-12-2025
- Dividend Yield
- STRM N/A
- TENX N/A
- EPS Growth
- STRM N/A
- TENX N/A
- EPS
- STRM N/A
- TENX N/A
- Revenue
- STRM $18,381,000.00
- TENX N/A
- Revenue This Year
- STRM $18.64
- TENX N/A
- Revenue Next Year
- STRM N/A
- TENX N/A
- P/E Ratio
- STRM N/A
- TENX N/A
- Revenue Growth
- STRM N/A
- TENX N/A
- 52 Week Low
- STRM $1.82
- TENX $2.80
- 52 Week High
- STRM $9.45
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- STRM 79.51
- TENX 53.61
- Support Level
- STRM $5.15
- TENX $5.70
- Resistance Level
- STRM $5.24
- TENX $6.65
- Average True Range (ATR)
- STRM 0.03
- TENX 0.54
- MACD
- STRM -0.09
- TENX 0.01
- Stochastic Oscillator
- STRM 80.00
- TENX 46.81
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.